Efficacy of Endoscopic Subureteral Injection for Vesicoureteral Reflux in Adults With Decreased Bladder Compliance

Samsung Medical Center47 enrolled

Overview

Endoscopic subureteral injection for vesicoureteral reflux has become an established alternative to ureter reimplantation in children. Some recent studies suggest that ESI can be also a primary treatment option for VUR in adults. However, the experience with ESI in adults who have VUR associated with decreased bladder compliance is limited. We evaluated the efficacy of endoscopic subureteral injection treatment for vesicoureteral reflux in adults with decreased bladder compliance.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Vesicoureteral Reflux

Interventions

Endoscopic subureteric injectionPROCEDURE

Endoscopic subureteric injection for the treatment of vesicoureteral reflux using variable materials (polydimethylsiloxane, collagen, and dextranomer/hyaluronic acid copolymer)

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Who is aged 18 and greater * Who underwent endoscopic subureteral injection for vesicoureteral reflux Exclusion Criteria: * Medical records of whom is not evaluabe

Locations (1)

Samsung Medical Center

Seoul, South Korea

Outcomes

Primary Outcomes

Cure rate

Time frame: 3, 12 months

Secondary Outcomes

adverse events

Time frame: 3, 12 months

predictive factor for cure

Time frame: 3, 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.